Cartiva Overview

  • Founded
  • 2011
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 11
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $435M
Latest Deal Amount

Cartiva General Information

Description

Developer of evidence-based medical devices intended for the treatment of cartilage damage and osteoarthritis. The company's devices uses a Premarket Approval (PMA), enabling patients to get musculoskeletal treatments at an affordable price.

Contact Information

Website
www.cartiva.net
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Other Healthcare
Primary Office
  • 6120 Windward Parkway
  • Suite 220
  • Alpharetta, GA 30005
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cartiva Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 10-Oct-2018 $435M 000.00 00000 Completed Generating Revenue
7. Later Stage VC (Series E) 18-Nov-2016 00.00 000.00 000.00 Completed Generating Revenue
6. Later Stage VC (Series D) 17-Apr-2015 00.00 000.00 000.00 Completed Generating Revenue
5. Later Stage VC (Series C) 29-Dec-2014 00.00 000.00 00.000 Completed Generating Revenue
4. Debt - General 08-Jan-2014 00.00 000.00 Completed Generating Revenue
3. Later Stage VC (Series C) 15-Jul-2013 00.00 000.00 00.000 Completed Generating Revenue
2. Early Stage VC (Series B) 28-Dec-2011 $3.65M $7.79M 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) $4.14M $4.14M Completed Generating Revenue
To view Cartiva’s complete valuation and funding history, request access »

Cartiva Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series E 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series D 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series C 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series B 1,739,125 $0.000100 $0.17 $2.1 $2.1 1x $0.22 20.25%
Series A 2,298,309 $0.000100 $0.14 $1.8 $1.8 1x $0.22 22.94%
To view Cartiva’s complete cap table history, request access »

Cartiva Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of evidence-based medical devices intended for the treatment of cartilage damage and osteoarthritis. The compa
Therapeutic Devices
Alpharetta, GA
11 As of 2015
000.00
0000 0000-00-00
000000&0 000.00

00000000

dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui
00000000000 0000000
Plymouth, MN
00 As of 0000
000.00
0000 0000-00-00
000000&0 000.00

00000000

ate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proiden
00000000000 0000000
Holland, MI
0 As of 0000
000.00
000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cartiva Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Rotation Medical Formerly VC-backed Plymouth, MN 00 000.00 000000&0 000.00
00000000 000000000 Venture Capital-Backed Holland, MI 0 000.00 000000000 000.00
0000000000000 Formerly VC-backed Franklin, MA 00 000.00 000000&0 000.00
0000000 Venture Capital-Backed Fremont, CA 00 00000 000000000 - 00000
000000000 00000000 Private Equity-Backed El Dorado Hills, CA 000.00 000000000 - 000.00
To view Cartiva’s complete competitors history, request access »

Cartiva Executive Team (9)

Name Title Board Seat Contact Info
Timothy Patrick Co-Founder, Chief Executive Officer, Board Member & President
Peter Pizzo III Chief Financial Officer & Vice President, Finance
Coit McDonald Director, Operations
Tanya Eberle Director, Regulatory Affairs
Carribeth Ramey Vice President, Engineering and Cartiva Manufacturing
You’re viewing 5 of 9 executive team members. Get the full list »

Cartiva Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cartiva Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alta Partners Venture Capital Minority 000 0000 000000 0
Domain Associates Venture Capital Minority 000 0000 000000 0
New Enterprise Associates Venture Capital Minority 000 0000 000000 0
Windham Venture Partners Venture Capital Minority 000 0000 000000 0
To view Cartiva’s complete investors history, request access »